Hypertensive Disorders in Pregnancy and the Risk of Cardiovascular Disease: A Need for Postpartum Strategies for the Primary Prevention

Código QR

Hypertensive Disorders in Pregnancy and the Risk of Cardiovascular Disease: A Need for Postpartum Strategies for the Primary Prevention

Guardado en:

Detalles Bibliográficos
Autor principal:	Ajay K. Gupta
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2018
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/742520cc61ca402b910b67fa57c899ae
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cardiovascular Sequels of Hypertension in Pregnancy
por: Renata Cífková
Publicado: (2018)

Do Young Women Need Treatment for Hypertension After Pregnancy Complications?
por: Christina Y. L. Aye, et al.
Publicado: (2018)

Progress continues on the management of pulmonary arterial hypertension in pregnancy
por: Hannah Douglas, et al.
Publicado: (2021)

De-risking primary prevention: role of imaging
por: Ahmed M. Shafter, et al.
Publicado: (2021)

The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
por: Pensée Wu, et al.
Publicado: (2021)

Trending cardiac biomarkers during pregnancy in women with cardiovascular disease
por: Soohyun Chang, et al.
Publicado: (2021)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Aarti Thakkar, et al.
Publicado: (2021)

Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
por: María Pilar Resano-Barrio, et al.
Publicado: (2020)

Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients
por: Jiang Li, et al.
Publicado: (2021)

Cardiovascular health and risk of hospitalization with COVID-19: A Mendelian Randomization study
por: Marina Cecelja, et al.
Publicado: (2021)

What cardiologists need to know about cardiovascular magnetic resonance (CMR)
por: J. Cameron Bridgman, et al.
Publicado: (2017)

Post-thrombotic Syndrome: Preventative and Risk Reduction Strategies Following Deep Vein Thrombosis
por: Adam M Gwozdz, et al.
Publicado: (2020)

Antifibrinolytic agents for the prevention of postpartum hemorrhage
por: Anne-Sophie Bouthors, et al.
Publicado: (2021)

Immigration Status and Sex Differences in Primary Cardiovascular Disease Prevention: A Retrospective Study of 5 Million Adults
por: Manav V. Vyas, et al.
Publicado: (2021)

Determinants of Pregnancy-Induced Hypertension among Mothers Attending Public Hospitals in Wolaita Zone, South Ethiopia: Findings from Unmatched Case-Control Study
por: Yitagesu Belayhun, et al.
Publicado: (2021)

Second-hand smoking, hypertension and cardiovascular risk: findings from Peru
por: Antonio Bernabe-Ortiz, et al.
Publicado: (2021)

Hypertension in Africa: Redressing the burden of cardiovascular disease using cost-effective nonpharmacological approaches
por: Gavin R. Norton, et al.
Publicado: (2017)

The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
por: Hargun Kaur, et al.
Publicado: (2021)

Impact of pregnancy and risk factors for ventricular arrhythmias in women with tetralogy of Fallot
por: Mette E Estensen, et al.
Publicado: (2021)

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Mattia Cattaneo, et al.
Publicado: (2019)

Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
por: Domenico D’Amario, et al.
Publicado: (2019)

New opportunities for reducing cardiovascular risk in the Russian Federation
por: O. D. Ostroumova, et al.
Publicado: (2020)

Systemic venous hypertension and low output are prevalent at catheterization in adults with pulmonary atresia and intact ventricular septum regardless of repair strategy
por: C. Charles Jain, et al.
Publicado: (2021)

Correction: Impact of pregnancy and risk factors for ventricular arrhythmias in women with tetralogy of Fallot
Publicado: (2021)

Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review
por: Esmee ME Bovee, et al.
Publicado: (2021)

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence
por: Koji Hasegawa, et al.
Publicado: (2019)

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
por: Olusola A Orimoloye, et al.
Publicado: (2019)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
por: Rhian M. Touyz, MBBCh, PhD, et al.
Publicado: (2021)

COVID-19: a patient with cardiovascular disease at high risk
por: Irina E. Chazova, et al.
Publicado: (2020)

Cardiovascular disease and nutrition: The use of food-based dietary guidelines for prevention in Africa
por: P.T. Pisa, et al.
Publicado: (2017)

Hypertension and Stroke: Update on Treatment
por: Mauricio Wajngarten, et al.
Publicado: (2019)

Pulmonary hypertension or cardiology aerobatics
por: I. E. Chazova, et al.
Publicado: (2020)

Systemic arterial hypertension and flight
por: Kaan Okyay
Publicado: (2021)

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?
por: Gianluigi Savarese
Publicado: (2019)

Cardiovascular Pharmacotherapy Focus
por: Pablo Avanzas
Publicado: (2019)

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
por: Charles Amir German, et al.
Publicado: (2020)

Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women
por: Per Eriksson, et al.
Publicado: (2021)

Pulmonary Hypertension in Heart Failure Patients
por: Sriram D Rao, et al.
Publicado: (2020)

Inflammation and Cardiovascular Disease: The Future
por: Natalie Arnold, et al.
Publicado: (2021)

Corrigendum to: Pulmonary Hypertension in Heart Failure Patients
por: Sriram D Rao, et al.
Publicado: (2020)